WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"
a white insoluble fibrous protein formed by the action of thrombin on fibrinogen when blood clots; it forms a network that traps red cells and platelets

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
(凝固血液中の)線維素,フィブリン

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 外科手術で使用される局所止血剤および生体組織接着剤の概要 overview of topical hemostatic agents and tissues adhesives used in surgery
2. フィブリンシーラント fibrin sealant
3. 幼児および小児における播種性血管内凝固 disseminated intravascular coagulation in infants and children
4. 出血性消化性潰瘍の治療の概要 overview of the treatment of bleeding peptic ulcers
5. フィブリノゲンの異常 disorders of fibrinogen

Management of a Previously Treated, Calcified, and Dilacerated Maxillary Lateral Incisor: A Combined Nonsurgical/Surgical Approach Assisted by Cone-beam Computed Tomography.

Dudeja PG1, Dudeja KK2, Garg A3, Srivastava D4, Grover S4.
Journal of endodontics.J Endod.2016 Apr 29. pii: S0099-2399(16)30109-1. doi: 10.1016/j.joen.2016.03.020. [Epub ahead of print]
Teeth with calcified canals, dilacerated roots, and associated large periradicular lesions involving both cortical plates pose a challenge to dentists. In addition to the nonsurgical endodontic treatment, such teeth may require surgical intervention with concomitant use of bone grafting materials an
PMID 27140443

Site-Specific Thiol-mediated PEGylation of Streptokinase Leads to Improved Properties with Clinical Potential.

Sawhney P, Kumar S, Maheshwari N, Guleria SS, Dhar N, Kashyup R, Sahni G1.
Current pharmaceutical design.Curr Pharm Des.2016 Feb 4. [Epub ahead of print]
Streptokinase (SK) is an efficient thrombolytic agent that dissolves fibrin blood clots with clinical efficiency comparable to the high priced drug, tissue plasminogen activator (tPA). However, being of bacterial origin, its major drawbacks are its potentially high antigenicity, and relatively short
PMID 26845325

The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.

Lai BF1, Zou Y, Brooks DE, Kizhakkedathu JN.
Biomaterials.Biomaterials.2010 Aug;31(22):5749-58. doi: 10.1016/j.biomaterials.2010.03.076.
Poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide (PDMDOMA) is a neutral synthetic water-soluble polymer. In this report, we evaluated the influence of PDMDOMA on blood hemostasis by studying the fibrin polymerization process, the three-dimensional clot structure, and the mechanical properties a
PMID 20435346